Breaking News

SFI commits to sharp minds with the Adopt-An-Herb Program for Bacopa monniera (brahmi)

Details

Created on Wednesday, 11 May 2011 10:14

The adoption of Bacopa monniera (brahmi) by SFI with the American Botanical Council’s Adopt-An-Herb program will ensure up-to-date clinical information for Bacopa monniera is easily available via HerbMedPro^TM.

Soho Flordis International (SFI) is an international provider of natural health solutions. SFI is a registered Australian company, born from the collaboration of two established organisations, Flordis Natural Medicines and SOHO Group, a leading Indonesian pharmaceutical company with international standard R&D, manufacturing and distribution and a natural medicine product range tailored for health care professionals.

HerbMedPro^TM is an electronic herbal database that provides hyperlinked access to the scientific data underlying the use of herbs for health. It is an evidence-based information resource for healthcare professionals, researchers, and the general public.

Flordis/SFI’s responsibility as adopter of Bacopa monniera is to keep information for all research on this valuable herb for cognitive health up-to-date. This will include Flordis’ KeenMind® (CDRI 08), with its specific Bacopa monniera formulation and seed-to-patient quality control. KeenMind^® is supported by clinical evidence demonstrating its efficacy as a cognitive enhancer with consistent results for memory, concentration and mental clarity. Flordis/SFI’s dedication to KeenMind^® and Bacopa monniera is also demonstrated by its commitment to additional clinical development to further examine its cognitive benefits.

In South Africa, KeenMind^® is available from leading pharmacies and health shops.

Access the latest clinical information on Bacopa monniera, the American Botanical Council’s Adopt-An-Herb program.